PTH and Hypocalcemia: We have identified a high baseline PTH as a risk factor for necessitating further titration of cinacalcet and proposed a baseline PTH > 30 pmol/L for initiating at full dose of 60 mg/day, though patients given 60 mg/day are at greater risk of hypocalcaemia.